Renhuang Wins Key Laboratory Designation
Renhuang Pharmaceuticals, Inc. (RHGP.OB) reported that its wholly-owned Traditional Chinese Medicine Extract and Innovation Laboratory ...
Is 3SBio Too Conservative to Move Forward?
In February 2007, the IPO from 3SBio (NSDQ: SSRX) made a big splash on Nasdaq. It was the first of the major China biopharma IPOs, and ...
China's Negative Economic Outlook
Certain recent developments in conjunction with prevailing global economic trends appear sufficiently serious to warrant a current econ...
Chinese Tech Stock Weekly Summary (6/23 - 6/29)
The following is excerpted from IRG's weekly stock report: ...
China Security & Surveillance: One To Watch Closely
On the heels of a follow-up report by the Security Industry Association (which very conservatively projects Chinese security industry s...
Tongjitang Slides After Buyout Offer Withdrawn
Tongjitang Chinese Medicines Company (NYSE: TCM) reported that the offer to buy the company has been withdrawn. The offer was made by T...
SOHU: China Plays With Growth Potential
Over the weekend, the big news was that a Chinese investment manager won the bidding to have lunch with Warren Buffet. Considering tha...
Anecdotal Evidence of Risks in China's Banking System
Before I talk about the banking system I just want to mention a quick story. After the 18% hike in fuel prices last week I wondered h...